Advertisement

Topics

Cyclica Company Profile

01:16 EST 21st January 2019 | BioPortfolio

Cyclica is a Toronto-based biotechnology company that is driving drug discovery by empowering scientists in pharma with an integrated cloud-based and AI-augmented platform that enhances how they design, screen and personalize medicines. To learn more, visit www.cyclicarx.com.


News Articles [14 Associated News Articles listed on BioPortfolio]

Merck KGaA takes ‘balanced risk’ with Cyclica’s AI platform

Merckâs agreement with Cyclica will establish efficiency in its small molecule therapy development with access to Cyclicaâs AI protein screening platform.

WuXi AppTec, Cyclica collaborate to advance drug discovery programs

Through a multi-phase collaboration, WuXi will leverage and evaluate Cyclica’s cloud-based proteome Ligand Express screening platform to investigate the off-target profiles of small molecules, apply...

Cyclica’s Cloud-Based Platform, Ligand Express, Will Help New Discovery Efforts in Bioactive ...

Cyclica Inc.Naheed KurjiPresident and CEOnaheed.kurji@cyclicarx.com Read more...

Merck partners with Cyclica for AI-based screening of drug targets

Merck has signed an agreement to licence Canadian Cyclica’s cloud-based in-silico proteome screening platform called Ligand Express to support its...Read More... The post Merck partners with Cyclica...

Cyclica, Bayer partner to advance drug discovery programs

The companies will advance drug discovery programs by gaining insights into the polypharmacological profiles of small molecules, while further evolving Cyclica’s integrated network of enabling techn...

Cyclica Drives Drug Discovery Through AI-Augmented Integrated Network of Cloud-Based Technologies together with Bayer

Cyclica (www.cyclicarx.com), a Bayer G4A company is pleased to announce a collaboration with Bayer to advance drug discovery programs by gaining insights into the polypharm...

Merck KGaA links with AI firm to iron out side-effects during R&D

Germany’s Merck KGaA has begun a licensing agreement with Canadian pharma R&D company Cyclica using artificial intelligence (AI) to uncover new drug targets and predict any side effects. Cyclic...

WuXi AppTec and Cyclica team to drive polypharmacology in drug discovery

The multi-phase collaboration between WuXi AppTec Research Service Division and Cyclica looks to advance polypharmacology in drug discovery using AI-augmented technology.

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Cyclica

Cyclica is a Toronto-based biotechnology company that is driving drug discovery by empowering scientists in pharma with an integrated cloud-based and AI-augmented platform that en...

Cyclica Inc.

Cyclica is a Toronto-based biotechnology company that is driving drug discovery by empowering scientists in pharma with an integrated cloud-based and AI-augmented platform that en...

More Information about "Cyclica" on BioPortfolio

We have published hundreds of Cyclica news stories on BioPortfolio along with dozens of Cyclica Clinical Trials and PubMed Articles about Cyclica for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cyclica Companies in our database. You can also find out about relevant Cyclica Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record